Dr. Trinh Dang is a Postdoctoral Research Fellow in Prof. Brandon Wainwright’s laboratory at the Frazer Institute, where her research focuses on the development of innovative cancer immunotherapies, with an emphasis on mRNA- and peptide-based approaches for brain cancers.
Dr. Dang received formal training in biochemistry and microbiology and transitioned into immunology during her doctoral research. Throughout her PhD, she developed skill sets in molecular biology, immunological assays, in vivo mouse models, and computational analyses, enabling her to integrate mechanistic biology with translational research.
She completed her Bachelor’s degree in Biochemistry with Class I Honours, followed by a Master’s degree in Biomedical Science. Dr. Dang undertook her PhD at the Frazer Institute, The University of Queensland, under the supervision of Emeritus Professor Ian Frazer (co-inventor of the Gardasil cervical cancer vaccine). Her doctoral work investigated the role of IL34 in HPV-induced skin cancer and inflammatory skin disease, combining functional immunology with lentiviral engineering, sequencing technologies, and bioinformatics analyses.
Dr. Dang then joined Prof. Wainwright’s group to advance next-generation immunotherapeutic strategies for cancer. Her current research aims to evaluate mRNA- and peptide-based immunotherapies for brain tumours.
Availability
Dr Trinh Dang is:
Available for supervision
Qualifications
Doctor of Philosophy of Tumour Immunology, The University of Queensland
